L-PAMPO
Mark Identification

L-PAMPO

Serial Number

79317594

Filing Date

Jun 23, 2021

Registration Date

Mar 7, 2023

Trademark by

CHA VACCINE RESEARCH INSTITUTE CO. LTD

Active Trademark

Classification Information

Vaccines for cattle; oral vaccine preparations; veterinary vaccines; viral vaccines; vaccines; adjuvants for use with vaccines; vaccine preparations; Veterinary substances and preparations for treating and preventing viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; human vaccine preparations; anti-microbial preparations for treating and preventing viruses and other infectious diseases; pharmaceutical preparations for treating and preventing viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; pharmaceutical compositions for the treatment and prevention of viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; reagents for medical use; diagnostic reagents for medical use for immunization diseases; diagnostic reagents for medical or veterinary purposes; clinical diagnostic reagents for medical use; preparations of microorganisms for medical or veterinary use; hepatitis vaccine; preparations for treatment of hepatitis; vaccines against flu; immunostimulants; immunomodulators; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; veterinary vaccines for bovine animals; veterinary vaccines for sheep; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for the treatment of cancer; drug delivery agents in the form of aqueous particles that provide a controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of injectable, inhalable, intranasal, oral, sublingual, transdermal, and topical compositions that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-infectives; anti-viral agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of tumours; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; compounds for treating cancer; pharmaceutical preparations and substances for the prevention of cancer

Pharmaceuticals